Atlas Trials

The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man

Clinical trial NCT02518932 · UNKNOWN

Trial details

NCT number
NCT02518932
Sponsor
Elahi, Dariush, PhD
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Insulin Resistance
Start date
2015-03-01
Primary completion
2016-03-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.